HomeAbout

TL;DR CNBC


Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations - TL;DR CNBC

Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations

Publishing timestamp: 2024-03-13 13:29:29


Summary

The legal battle over Medicare drug price negotiations is heating up, with the Biden administration facing lawsuits from drugmakers. Despite some early wins for the administration, the pharmaceutical industry is aiming to escalate the fight to the Supreme Court. Meanwhile, the HIMSS global health conference is underway, with a focus on AI in healthcare. Companies like Salesforce and Microsoft have already made announcements regarding AI solutions in the healthcare sector.


Sentiment: MIXED

Tickers: AZN-GBMRKJNJAZN

Keywords: biotech and pharmaceuticalsastrazeneca plcunited statesjohnson & johnsonbusiness newsjoe bidenhealth care industrymerck & co inc

Source: https://www.cnbc.com/2024/03/13/healthy-returns-whats-next-in-medicare-drug-price-negotiations.html


Developed by Leo Phan